MSA
ABMD

Marino Stram & Associates’s Abiomed Inc ABMD Stock Holding History

Marino Stram & Associates’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7
Closed -$2K – 602
2019
Q1 		$2K Buy
7
+2
+40% +$665 ﹤0.01% 561
2018
Q4 		$2K Buy
+5
New +$1.74K ﹤0.01% 521

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Marino Stram & Associates's ABMD Position: Q2 2019 in Review

Marino Stram & Associates sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 7 shares — an estimated $2K sold.

Marino Stram & Associates first reported a position in ABMD in Q4 2018 and held it in 2 quarters. The position peaked at $2K in Q1 2019. 483 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Marino Stram & Associates reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 7 Abiomed Inc shares in Q2 2019, an estimated $2K.
  • Marino Stram & Associates first reported a position in Abiomed Inc in Q4 2018 and held it in 2 quarters.
  • Marino Stram & Associates's Abiomed Inc position peaked at $2K in Q1 2019.
  • 483 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.